Document
IPR2016-01096, No. 8 Power of Attorney - Power of Attorney (P.T.A.B. Jun. 20, 2016)
Cite Document
IPR2016-01096, No. 8 Power of Attorney - Power of Attorney (P.T.A.B. Jun. 20, 2016)
+ More Snippets
Document
IPR2016-01096, No. 2 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
Cite Document
IPR2016-01096, No. 2 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
+ More Snippets
Document
IPR2016-01096, No. 3 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
Cite Document
IPR2016-01096, No. 3 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
+ More Snippets
Document
IPR2016-01096, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
Cite Document
IPR2016-01096, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
+ More Snippets
Document
IPR2016-01096, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
Cite Document
IPR2016-01096, No. 4 Power of Attorney - Power of Attorney (P.T.A.B. May. 31, 2016)
+ More Snippets
Document
IPR2016-01096, No. 2081-92 Exhibit - July 13, 2017 Deposition Testimony of Dr Patrick DeLuca (P.T.A.B. Jul. 24, 2017)
Cite Document
IPR2016-01096, No. 2081-92 Exhibit - July 13, 2017 Deposition Testimony of Dr Patrick DeLuca (P.T.A.B. Jul. 24, 2017)
+ More Snippets
Document
IPR2016-01096, No. 1042-81 Exhibit - Lupron Label, Center for Drug Evaluation Research, Application No NDA 19732S012 (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01096, No. 1042-81 Exhibit - Lupron Label, Center for Drug Evaluation Research, Application No NDA 19732S012 (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01096, No. 1038-77 Exhibit - US Patent No 5,417,982 (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01096, No. 1038-77 Exhibit - US Patent No 5,417,982 (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2063-58 Exhibit - Exh 2063 Ashland 7ELC1 Certificate of Analysis (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2063-58 Exhibit - Exh 2063 Ashland 7ELC1 Certificate of Analysis (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2050-47 Exhibit - Exh 2050 Rainer 2008 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2050-47 Exhibit - Exh 2050 Rainer 2008 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2047-44 Exhibit - Exh 2047 Wang 2005 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2047-44 Exhibit - Exh 2047 Wang 2005 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2041-38 Exhibit - Exh 2041 Risperdal Consta FDA Clinical Review (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2041-38 Exhibit - Exh 2041 Risperdal Consta FDA Clinical Review (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2052-67 Exhibit - Exh 2052 Ashland Press Release (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2052-67 Exhibit - Exh 2052 Ashland Press Release (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2015-12 Exhibit - Exh 2015 CV of Dr Cory Berkland (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01096, No. 2015-12 Exhibit - Exh 2015 CV of Dr Cory Berkland (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01096, No. 2012-9 Exhibit - Declaration in Support of Patent Owners Motion for Pro Hac Vice Admission of Melinda R Roberts (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2016-01096, No. 2012-9 Exhibit - Declaration in Support of Patent Owners Motion for Pro Hac Vice Admission of Melinda R Roberts (P.T.A.B. Feb. 2, 2017)
+ More Snippets